Product Selection Committee / Comité de sélection des produits
|
|
|
- Amberlynn Morrison
- 5 years ago
- Views:
Transcription
1 New Brunswick Pharmaceutical Society and New Brunswick Department of Health Product Selection Committee / Comité de sélection des produits L Ordre des pharmaciens P.O. Box / C.P. 5100, Fredericton NB E3B 5G8 du Nouveau-Brunswick Tel.: (506) Fax: (506) et le ministère de la Santé du Nouveau-Brunswick Volume 49, Update No.3 March 4, 2008 New Brunswick Formulary, Volume 49 Product Updates The drug products on the attached list have been added to the interchangeable pharmaceutical products list. Product selection, using these additions, can begin immediately for all residents of the province. Please update your current copy of the New Brunswick Formulary with the changes on the attached list. These changes in the interchangeable products list do not necessarily reflect changes in drug benefit plan formularies. Please check with individual third party payers regarding benefit status. Responsible For Determining The Interchangeability of Pharmaceutical Products Responsable de déterminer quels sont les produits pharmaceutiques interchangeables
2 Atenolol Aténolol Tab Orl 25mg Gen-Atenolol GPM Atenolol/Chlorthalidone aténolol/chlorthalidone Tab Orl 50mg/25mg Novo-Atenolthalidone NOP 100mg/25mg Novo-Atenolthalidone NOP Bicalutamide Tab Orl 50mg Apo-Bicalutamide APX Gen-Bicalutamide GPM Bisoprolol Fumarate Fumarate de bisoprolol Tab Orl 5mg pms-bisoprolol PMS 10mg pms-bisoprolol PMS Citalopram Hydrobromide Citalopram (bromhydrate de) Tab Orl 40mg Novo-Citalopram (new formulation) NOP Clindamycin Hydrochloride Clindamycine (chlorhydrate de) Cap Orl 150mg pms-clindamycin PMS Caps 300mg pms-clindamycin PMS Enalapril Maleate/Hydrochlorothiazide Énalapril (maléate de)/hydrochlorothiazide Tab Orl 5mg/12.5mg Vaseretic FRS Novo-Enalapril/HCTZ NOP 10mg/25mg Vaseretic FRS Novo-Enalapril/HCTZ NOP Fluconazole Tab Orl 50mg Co-Fluconazole COB 100mg Co-Fluconazole COB Gliclazide Tab Orl 80mg pms-gliclazide PMS NB Formulary / Le Formulaire du N-B Page 1 March/mars 2008
3 Isosorbide -5- Mononitrate Isosorbide (5-mononitrate d') SRT Orl 60mg pms-ismn PMS L.L. Lisinopril/Hydrochlorothiazide Tab Orl 10mg/12.5mg Prinzide FRS Zestoretic AZE Novo-Lisinopril HCTZ (Type P) NOP Novo-Lisinopril HCTZ (Type Z) NOP 20mg/12.5mg Prinzide FRS Zestoretic AZE Novo-Lisinopril HCTZ (Type P) NOP Novo-Lisinopril HCTZ (Type Z) NOP 20mg/25mg Prinzide FRS Zestoretic AZE Novo-Lisinopril HCTZ (Type P) NOP Novo-Lisinopril HCTZ (Type Z) NOP Metoprolol Tartrate Métoprolol (tartrate de) Tab Orl 25mg Apo-Metoprolol APX Gen-Metoprolol (Type L) GPM Minocycline Hydrochloride Minocycline (chlorhydrate de) Cap Orl 50mg pms-minocycline PMS Caps 100mg pms-minocycline PMS Pioglitazone Hydrochloride Pioglitazone, chlorhydrate de Tab Orl 15mg Co-Pioglitazone COB pms-pioglitazone PMS 30mg Co-Pioglitazone COB pms-pioglitazone PMS 45mg Co-Pioglitazone COB pms-pioglitazone PMS Ramipril Cap Orl 1.25mg Co-Ramipril COB Caps 2.5mg Co-Ramipril COB 5mg Co-Ramipril COB 10mg Co-Ramipril COB NB Formulary / Le Formulaire du N-B Page 2 March/mars 2008
4 Temazepam Témazépam Cap Orl 15mg pms-temazepam PMS Caps 30mg pms-temazepam PMS Venlafaxine Hydrochloride Venlafaxine (chlorhydrate de) SRC Orl 37.5mg pms-venlafaxine XR PMS Caps. L.L. 75mg pms-venlafaxine XR PMS 150mg pms-venlafaxine XR PMS NB Formulary / Le Formulaire du N-B Page 3 March/mars 2008
5 New Brunswick Pharmaceutical Society and New Brunswick Department of Health Product Selection Committee / Comité de sélection des produits L Ordre des pharmaciens P.O. Box / C.P. 5100, Fredericton NB E3B 5G8 du Nouveau-Brunswick Tel.: (506) Fax: (506) et le ministère de la Santé du Nouveau-Brunswick Volume 49, Update No.4 June 2, 2008 New Brunswick Formulary, Volume 49 Product Updates The drug products on the attached list have been added to the interchangeable pharmaceutical products list. Product selection, using these additions, can begin immediately for all residents of the province. Please update your current copy of the New Brunswick Formulary with the changes on the attached list. These changes in the interchangeable products list do not necessarily reflect changes in drug benefit plan formularies. Please check with individual third party payers regarding benefit status. Responsible For Determining The Interchangeability of Pharmaceutical Products Responsable de déterminer quels sont les produits pharmaceutiques interchangeables
6 Acetaminophen/oxycodone hydrochloride Acétaminophène/oxycodone (chlorhydrate d') Tab Orl 325mg/5mg Novo-Oxycodone Acet NOP Brimonidine Tartrate Liq Oph 0.2% Sandoz-Brimonidine SDZ Cabergoline Tab Orl 0.5mg Dostinex SQI Co-Cabergoline COB Ciclopirox Liq Top 8% Penlac SAV Apo-Ciclopirox APX Citalopram Hydrobromide Citalopram (bromhydrate de) Tab Orl 20mg Mint-Citalopram MNT 40mg Mint-Citalopram MNT Deferoxamine Mesylate Déféroxamine (mésylate de) Pws Inj 2g pms-deferoxamine PMS Pds. Metoprolol Tartrate Métoprolol (tartrate de) SRT Orl 100mg Sandoz-Metoprolol SR SDZ L.L. 200mg Sandoz-Metoprolol SR SDZ Modafinil Tab Orl 100mg Alertec SHB Apo-Modafinil APX Morphine Sulfate Morphine (sulfate de) SRT Orl 60mg Novo-Morphine SR NOP L.L. 100mg MS Contin PFR Novo-Morphine SR NOP pms-morphine Sulfate SR PMS NB Formulary / Le Formulaire du N-B Page 1 June/juin 2008
7 Morphine Sulfate Morphine (sulfate de) SRT Orl 200mg MS Contin PFR L.L. Novo-Morphine SR NOP pms-morphine Sulfate SR PMS Olanzapine Tab Orl 2.5mg pms-olanzapine PMS 5mg pms-olanzapine PMS 7.5mg pms-olanzapine PMS 10mg pms-olanzapine PMS 15mg pms-olanzapine PMS Ondansetron Hydrochloride Dihydrate Ondansétron dihydraté (chlorhydrate d') Liq Orl 4mg/5mL Zofran GSK Apo-Ondansetron APX Pantoprazole Sodium Pantoprazole sodique ECT Orl 20mg Pantoloc NYC Ent. Apo-Pantoprazole APX Novo-Pantoprazole NOP Ran-Pantoprazole RAN 40mg Pantoloc NYC Apo-Pantoprazole APX Novo-Pantoprazole NOP Ran-Pantoprazole RAN Propafenone Hydrochloride Propafénone (chlorhydrate de) Tab Orl 150mg pms-propafenone (new formulation) PMS 300mg pms-propafenone (new formulation) PMS Ramipril Cap Orl 2.5mg Ramipril PMS Caps 5mg Ramipril PMs 10mg Ramipril PMS NB Formulary / Le Formulaire du N-B Page 2 June/juin 2008
8 Risperidone Rispéridone Tab Orl 0.5mg Sandoz-Risperidone (new formulation) SDZ Timolol Maleate Timolol (maléate de) Liq Oph 0.5% Apo-Timop Gel APX Venlafaxine Hydrochloride Venlafaxine (chlorhydrate de) SRC Orl 37.5mg Co-Venlafaxine XR COB Caps. L.L. 75mg Co-Venlafaxine XR COB 150mg Co-Venlafaxine XR COB NB Formulary / Le Formulaire du N-B Page 3 June/juin 2008
9 New Brunswick Pharmaceutical Society and New Brunswick Department of Health Product Selection Committee / Comité de sélection des produits L Ordre des pharmaciens P.O. Box / C.P. 5100, Fredericton NB E3B 5G8 du Nouveau-Brunswick Tel.: (506) Fax: (506) et le ministère de la Santé du Nouveau-Brunswick Volume 50, Update No.1 September 18, 2008 New Brunswick Formulary, Volume 50 Product Updates The drug products on the attached list have been added to the interchangeable pharmaceutical products list. Product selection, using these additions, can begin immediately for all residents of the province. Please update your current copy of the New Brunswick Formulary with the changes on the attached list. These changes in the interchangeable products list do not necessarily reflect changes in drug benefit plan formularies. Please check with individual third party payers regarding benefit status. Responsible For Determining The Interchangeability of Pharmaceutical Products Responsable de déterminer quels sont les produits pharmaceutiques interchangeables
10 Brimonidine Tartrate Liq Oph 0.15% Alphagan P ALL Apo-Brimonidine P APX Butalbital/Acetylsalicylic Acid/Caffeine Butalbital/acide acétylsalicylique/caféine Cap Orl 50mg/330mg/40mg Fiorinal NVR Caps ratio-tecnal RPH Butalbital/Acetylsalicylic Acid/Caffeine/Codeine Phosphate Butalbital/acide acétylsalicylique/caféine/codéine (phosphate de) Cap Orl 50mg/330mg/40mg/15mg Fiorinal C1/ NVR Caps ratio-tecnal C1/ RPH Butalbital/Acetylsalicylic Acid/Caffeine/Codeine Phosphate Butalbital/acide acétylsalicylique/caféine/codéine (phosphate de) Cap Orl 50mg/330mg/40mg/30mg Fiorinal C1/ NVR Caps ratio-tecnal C1/ RPH Cefazolin Sodium Céfazoline sodique Pws Inj 500mg Cefazolin Sodium NOP Pds Cefazolin SDZ 1gm Cefazolin Sodium NOP Cefazolin SDZ Ceftriaxone Disodium Ceftriaxone disodique Pws Inj 250mg Rocephin HLR Pds Ceftriaxone APX 1gm Ceftriaxone APX 10gm Rocephin HLR Ceftriaxone APX Ciprofloxacin Hydrochloride Ciprofloxacine (chlorhydrate de) Tab Orl 250mg Ran-Ciproflox RAN 500mg Ran-Ciproflox RAN 750mg Ran-Ciproflox RAN Clonidine Hydrochloride Clonidine (chlorhydrate de) Tab Orl 0.025mg Novo-Clonidine NOP NB Formulary / Le Formulaire du N-B Page 1 September/septembre 2008
11 Cyclosporine Liq Orl 100mg/mL Neoral NVR Apo-Cyclosporine APX Fentanyl Transdermal Fentanyl transdermal de Srd Trd 12mcg Duragesic JAN ratio-fentanyl RPH Gabapentin Gabapentine Tab Orl 600mg Apo-Gabapentin APX 800mg Apo-Gabapentin APX Gliclazide ERT Orl 30mg Diamicron MR SEV L.P. Apo-Gliclazide MR APX Naproxen ECT Orl 375mg pms-naproxen EC PMS Ent. 500mg pms-naproxen EC PMS Pantoprazole Sodium Pantoprazole sodique ECT Orl 20mg ratio-pantoprazole RPH Ent. Sandoz-Pantoprazole SDZ 40mg Co-Pantoprazole COB Gen-Pantoprazole GPM pms-pantoprazole PMS ratio-pantoprazole RPH Sandoz-Pantoprazole SDZ Quetiapine Fumarate Quétiapine (fumarate de) Tab Orl 25mg Seroquel AZE Co-Quetiapine COB Gen-Quetiapine GPM Novo-Quetiapine NOP pms-quetiapine PMS ratio-quetiapine RPH 100mg Seroquel AZE Co-Quetiapine COB Gen-Quetiapine GPM Novo-Quetiapine NOP pms-quetiapine PMS ratio-quetiapine RPH NB Formulary / Le Formulaire du N-B Page 2 September/septembre 2008
12 Quetiapine Fumarate Quétiapine (fumarate de) Tab Orl 200mg Seroquel AZE Co-Quetiapine COB Gen-Quetiapine GPM Novo-Quetiapine NOP pms-quetiapine PMS ratio-quetiapine RPH 300mg Seroquel AZE Co-Quetiapine COB Gen-Quetiapine GPM Novo-Quetiapine NOP pms-quetiapine PMS ratio-quetiapine RPH Ramipril Cap Orl 1.25mg Gen-Ramipril GPM Caps 2.5mg Gen-Ramipril GPM 5mg Gen-Ramipril GPM 10mg Gen-Ramipril GPM Valacyclovir Tab Orl 500mg Valtrex GSK Apo-Valacyclovir APX pms-valacyclovir PMS Venlafaxine Hydrochloride Venlafaxine (chlorhydrate de) SRC Orl 37.5mg Gen-Venlafaxine XR GPM Caps. L.L. Sandoz-Venlafaxine XR SDZ 75mg Gen-Venlafaxine XR GPM Sandoz-Venlafaxine XR SDZ 150mg Gen-Venlafaxine XR GPM Sandoz-Venlafaxine XR SDZ NB Formulary / Le Formulaire du N-B Page 3 September/septembre 2008
13 New Brunswick Pharmaceutical Society and New Brunswick Department of Health Product Selection Committee / Comité de sélection des produits L Ordre des pharmaciens P.O. Box / C.P. 5100, Fredericton NB E3B 5G8 du Nouveau-Brunswick Tel.: (506) Fax: (506) et le ministère de la Santé du Nouveau-Brunswick Volume 50, Update No.2 December 10, 2008 New Brunswick Formulary, Volume 50 Product Updates The drug products on the attached list have been added to the interchangeable pharmaceutical products list. Product selection, using these additions, can begin immediately for all residents of the province. Please update your current copy of the New Brunswick Formulary with the changes on the attached list. These changes in the interchangeable products list do not necessarily reflect changes in drug benefit plan formularies. Please check with individual third party payers regarding benefit status. Responsible For Determining The Interchangeability of Pharmaceutical Products Responsable de déterminer quels sont les produits pharmaceutiques interchangeables
14 Alfuzosin Hydrochloride Alfuzosine (chlorhydrate d') ERT Orl 10mg Xatral SAV L.P. Apo-Alfuzosin APX Bupropion Hydrochloride Bupropion (chlorhydrate de) SRT Orl 150mg pms-bupropion SR PMS L.L. Cefazolin Sodium Céfazoline sodique Pws Inj 1gm Cefazolin APX Pds. 10gm Cefazolin APX Citalopram Hydrobromide Citalopram (bromhydrate de) Tab Orl 20mg Jamp-Citalopram JPC Odan-Citalopram ODN 40mg Jamp-Citalopram JPC Odan-Citalopram ODN Diclofenac Sodium Diclofénac sodique Sup Rt 50mg Sandoz-Diclofenac (new formulation) SDZ Supp. 100mg Sandoz-Diclofenac (new formulation) SDZ Diltiazem Hydrochloride Diltiazem (chlorhydrate de) ERC Orl 120mg Apo-Diltiazem TZ APX Caps. L.P. 180mg Apo-Diltiazem TZ APX 240mg Apo-Diltiazem TZ APX 300mg Apo-Diltiazem TZ APX 360mg Apo-Diltiazem TZ APX Etidronate Disodium/carbonate Etidronate disodique/carbonate d' Tab Orl 400mg/500mg Didrocal PGA Co-Etidrocal COB NB Formulary / Le Formulaire du N-B Page 1 December/décembre 2008
15 Famciclovir Tab Orl 125mg Co-Famciclovir COB 250mg Co-Famciclovir COB 500mg Co-Famciclovir COB Gabapentin Gabapentine Tab Orl 600mg pms-gabapentin PMS 800mg pms-gabapentin PMS Leflunomide Léflunomide Tab Orl 10mg Gen-Leflunomide GPM 20mg Gen-Leflunomide GPM Ondansetron Hydrochloride Dihydrate Ondansétron dihydraté (chlorhydrate d') Tab Orl 4mg Mint-Ondansetron MNT Odan-Ondansetron ODN 8mg Mint-Ondansetron MNT Odan-Ondansetron ODN Paroxetine Tab Orl 10mg Sandoz-Paroxetine (new formulation) SDZ 20mg Sandoz-Paroxetine (new formulation) SDZ 30mg Sandoz-Paroxetine (new formulation) SDZ Piperacillin Sodium/Tazobactam Sodium Pipéracilline sodique/tazobactam sodique Pws Inj 2g/0.25g Tazocin WAY Pds. Piperacillin & Tazobactam APX 3g/0.375g Tazocin WAY Piperacillin & Tazobactam APX 4g/0.5g Tazocin WAY Piperacillin & Tazobactam APX NB Formulary / Le Formulaire du N-B Page 2 December/décembre 2008
16 Pramipexole Dihydrochloride (monohydrate) Tab Orl 0.25mg Sandoz-Pramipexole SDZ 0.5mg Sandoz-Pramipexole SDZ 1mg Sandoz-Pramipexole SDZ 1.5mg Sandoz-Pramipexole SDZ Quetiapine Fumarate Quétiapine (fumarate de) Tab Orl 25mg Apo-Quetiapine APX Sandoz-Quetiapine SDZ 100mg Apo-Quetiapine APX Sandoz-Quetiapine SDZ 150mg Seroquel (DISC) AZE Novo-Quetiapine NOP 200mg Apo-Quetiapine APX Sandoz-Quetiapine SDZ 300mg Apo-Quetiapine APX Sandoz-Quetiapine SDZ Rabeprazole Sodium Rabéprazole sodique ECT Orl 10mg pms-rabeprazole EC PMS Ent. 20mg pms-rabeprazole EC PMS Ranitidine Hydrochloride Ranitidine (chlorhydrate de) Tab Orl 75mg Apo-Ranitidine (new formulation) APX 150mg Apo-Ranitidine (new formulation) APX 300mg Apo-Ranitidine (new formulation) APX Vitamin D2 Vitamin d2 Dps Orl 8288IU/mL Drisdol SAV Gttes Erdol (Drisodan) ODN NB Formulary / Le Formulaire du N-B Page 3 December/décembre 2008
Product Selection Committee / Comité de sélection des produits
New Brunswick Pharmaceutical Society and New Brunswick Department of Health Product Selection Committee / Comité de sélection des produits L Ordre des pharmaciens P.O. Box / C.P. 5100, Fredericton NB E3B
NBPDP Formulary Update
Bulletin # 830 April 4, 2012 NBPDP Formulary Update Please find attached lists of interchangeable product additions to the New Brunswick Prescription Drug Program Formulary and non-listed products subject
UPDATE B Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective October 01, 2008 SUMMARY OF CHANGES
UPDATE B Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective October 01, 2008 SUMMARY OF CHANGES TABLE OF CONTENTS Page New Multi-Source Drug(s) 2 Manufacturer Requested Discontinued
NB Drug Plans Formulary Update
Bulletin #915 October 30, 2015 NB Drug Formulary Update Please find attached a list of generic drug product updates for the New Brunswick Drug Formulary. Generic drug product additions New generic products
UPDATE C Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective November 04, 2008 SUMMARY OF CHANGES
UPDATE C Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective November 04, 2008 SUMMARY OF CHANGES TABLE OF CONTENTS Page New Single Source Drug(s) 2 New Multi-Source Drug(s) 3 Exceptional
Manager, PEI Drug Programs Date : December 7, 2009 Tel / Tél : (902) Fax / Téléc : (902)
DRAFT To / Destinataire : All Retail Pharmacists and Staff From / Expéditeur : Faye Campbell Manager, PEI Drug Programs Date : December 7, 2009 Tel / Tél : (902) 368-6338 Fax / Téléc : (902) 368-4905 Subject
SASKATCHEWAN FORMULARY COMMITTEE BULLETIN TO THE 58th EDITION OF THE SASKATCHEWAN FORMULARY
Saskatchewan Ministry of Health Drug Plan and Extended Benefits Branch July 2008 Bulletin #115 ISSN 0708-3246 SASKATCHEWAN FORMULARY COMMITTEE BULLETIN TO THE 58th EDITION OF THE SASKATCHEWAN FORMULARY
NB Drug Plans Formulary Update
Bulletin #973 April 30, 2018 NB Drug Plans Formulary Update Generic drug product updates included in this bulletin: Generic drug product additions - New generic products will be reimbursed up to the category
NB Drug Plans Formulary Update
Bulletin #960 October 31, 2017 NB Drug Formulary Update Please find attached a list of generic drug product updates for the New Brunswick Drug Formulary. Generic drug product additions New generic products
UPDATE C Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective November 04, 2008 SUMMARY OF CHANGES
UPDATE C Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective November 04, 2008 SUMMARY OF CHANGES TABLE OF CONTENTS Page New Single Source Drug(s) 2 New Multi-Source Drug(s) 3 Exceptional
SASKATCHEWAN FORMULARY COMMITTEE BULLETIN UPDATE TO THE 57th EDITION OF THE SASKATCHEWAN FORMULARY
Saskatchewan Health Drug Plan and Extended Benefits Branch April 2008 Bulletin #114 ISSN 0708-3246 SASKATCHEWAN FORMULARY COMMITTEE BULLETIN UPDATE TO THE 57th EDITION OF THE SASKATCHEWAN FORMULARY The
UPDATE E Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective December 23, 2008 SUMMARY OF CHANGES
UPDATE E Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective December 23, 2008 SUMMARY OF CHANGES TABLE OF CONTENTS Page New Multi-Source Drug(s) 2 New Drug Identification Number(s)
CLAIM SUBMISSION QUANTITIES
Bulletin #704 January 11, 2008 CLAIM SUBMISSION QUANTITIES Please find attached a list of the units of measure to be used when determining the quantity for NBPDP claim submissions. Using the correct units
PEI Drug Programs. Issue October, 2006
PEI Drug Programs Formulary Update Issue 06-04 October, 2006 The following changes and additions to the July 2006 edition of the PEI Drug Programs Formulary will be effective th October 16, 2006 unless
Pharmacy Consultant, PEI Drug Programs Date : September 8, 2009 Tel / Tél : (902) Fax / Téléc : (902)
To / Destinataire : All Retail Pharmacists and Staff From / Expéditeur : Patrick Crawford Pharmacy Consultant, PEI Drug Programs Date : September 8, 2009 Tel / Tél : (902) 368-6711 Fax / Téléc : (902)
Product Selection Committee / Comité de sélection des produits
New Brunswick Pharmaceutical Society and NB Department of Health & Wellness Product Selection Committee / Comité de sélection des produits L Ordre des pharmaciens P.O. Box / C.P. 5100, Fredericton NB E3B
UPDATE AF Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective March 26, 2012 SUMMARY OF CHANGES
UPDATE AF Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective March 26, 2012 SUMMARY OF CHANGES TABLE OF CONTENTS Page New Multi-Source Drug(s) 2 Off Formulary Interchangeable Product(s)
Archived Content. This content was archived on June 24, 2013.
This content was archived on June 24, 2013. Archived Content Information identified as archived on the Web is for reference, research or recordkeeping purposes. It has not been altered or updated after
SASKATCHEWAN FORMULARY BULLETIN Update to the 60th Edition of the Saskatchewan Formulary
Saskatchewan Ministry of Health November 1, 2010 Drug Plan and Extended Benefits Branch Bulletin #126 ISSN 1923-077X SASKATCHEWAN FORMULARY BULLETIN Update to the 60th Edition of the Saskatchewan Formulary
Riesbeck's Pharmacy Reward Club Generic Medication List October 2017
Allergy, Cold & Flu Antibiotic Treatments Arthritis & Pain Benzonatate 100mg cap 14 42 Diphenhydramine HCl Cap 50 MG 30 90 Diphenhydramine HCl Inj 50MG/ML 1 3 Diphenhydramine HCl Liquid 12.5 MG/5ML 720ml
Riesbeck's Pharmacy Reward Club Generic Medication List September 2017
Drug Category Allergy, Cold & Flu Antibiotic Treatments Arthritis & Pain Riesbeck's Benzonatate 100mg cap 14 42 Diphenhydramine HCl Cap 50 MG 30 90 Diphenhydramine HCl Liquid 12.5 MG/5ML 720ml 2160ml Hydroxyzine
Riesbeck's Pharmacy Reward Club Generic Medication List February 2018 $4 30 Day Supply
Allergy, Cold & Flu Antibiotic Treatments Arthritis & Pain Benzonatate 100mg cap 14 42 Diphenhydramine HCl Cap 50 MG 30 90 Diphenhydramine HCl Inj 50MG/ML 1 3 Diphenhydramine HCl Liquid 12.5 MG/5ML 720ml
NBPDP Formulary Update
Bulletin # 853 January 31, 2013 NBPDP Formulary Update Please find attached lists of interchangeable product additions to the New Brunswick Prescription Drug Program Formulary and non-listed products subject
Alaska Medicaid 90 Day** Generic Prescription Medication List
1 ACYCLOVIR 200 MG CAPSULE BUPROPION HCL 150 MG TAB ER 24H ACYCLOVIR 200 MG/5ML BUPROPION HCL 150 MG TABLET ER ACYCLOVIR 400 MG TABLET BUPROPION HCL 150 MG TABLET ER ACYCLOVIR 800 MG TABLET BUPROPION HCL
NBPDP Formulary Update
Bulletin # 880 January 28, 2014 NBPDP Formulary Update Please find attached a list of interchangeable product additions to the New Brunswick Prescription Drug Program Formulary. Existing interchangeable
SASKATCHEWAN FORMULARY COMMITTEE BULLETIN FOR THE UPDATE TO THE 56th EDITION OF THE SASKATCHEWAN FORMULARY
Saskatchewan Health Drug Plan and Extended Benefits Branch January 2007 Bulletin #109 ISSN 0708-3246 SASKATCHEWAN FORMULARY COMMITTEE BULLETIN FOR THE UPDATE TO THE 56th EDITION OF THE SASKATCHEWAN FORMULARY
UPDATE AJ Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective July 27, 2012 SUMMARY OF CHANGES
UPDATE AJ Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective July 27, 2012 SUMMARY OF CHANGES TABLE OF CONTENTS Page New Single Source Drug(s) 2 New Multi-Source Drug(s) 5 Off Formulary
NB Drug Plans Formulary Update
Bulletin #984 October 31, 2018 NB Drug Formulary Update Drug product updates included in this bulletin: Drug product additions - New generic products will be reimbursed up to the category Maximum Allowable
New Interchangeable Products Approved and Benefit Status Within the Nova Scotia Pharmacare Programs March 2016
PAGE 1 OF 6 New Interchangeable Products Approved and Benefit Status Within the Nova Scotia Pharmacare Programs March New Categories A Maximum Reimbursable Price (MRP) or Pharmacare Reimbursement Price
Ontario Drug Benefit Formulary/Comparative Drug Index
Ministry of Health and Long-Term Care Ontario Drug Benefit Formulary/Comparative Drug Index Edition 43 Summary of Changes June 2018 Effective June 29, 2018 Drug Programs Policy and Strategy Branch Ontario
UPDATE F Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective 30 January, 2009 SUMMARY OF CHANGES
UPDATE F Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective 30 January, 2009 SUMMARY OF CHANGES TABLE OF CONTENTS Page New Single Source Drug(s) 2 New Multi-Source Drug(s) 3 Manufacturer
UPDATE AU Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective May 31, 2013 SUMMARY OF CHANGES
UPDATE AU Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective May 31, 2013 SUMMARY OF CHANGES TABLE OF CONTENTS Page New Multi-Source Drug(s) 2 Off Formulary Interchangeable Product(s)
BULLETIN # 70. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on January 21, 2013
BULLETIN # 70 Manitoba Drug Benefits and Interchangeability Formulary Amendments The following amendments will take effect on January 21, 2013 The amended Manitoba Specified Drug Regulation and Drug Interchangeability
SASKATCHEWAN FORMULARY BULLETIN. Update to the 60th Edition of the Saskatchewan Formulary
Saskatchewan Ministry of Health July 1, 2010 Drug Plan and Extended Benefits Branch Bulletin #124 ISSN 1923-077X SASKATCHEWAN FORMULARY BULLETIN Update to the 60th Edition of the Saskatchewan Formulary
Ontario Drug Benefit Formulary/Comparative Drug Index
Ministry of Health and Long-Term Care Ontario Drug Benefit Formulary/Comparative Drug Index Edition 42 Summary of Changes - October 2015 Effective October 29, 2015 Drug Program Services Branch/Ontario
Ontario Drug Benefit Formulary/ Comparative Drug Index
Ontario Drug Benefit Formulary/ Comparative Drug Index Edition 42 Summary of Changes December 2013 Effective January 03, 2014 Ministry of Health and Long-Term Care Table of Contents Additions to Formulary...
Updates to the Alberta Drug Benefit List. Effective February 1, 2018
Updates to the Alberta Drug Benefit List Effective February 1, 2018 Inquiries should be directed to: Pharmacy Services Alberta Blue Cross 10009 108 Street NW Edmonton AB T5J 3C5 Telephone Number: (780)
BULLETIN # 73. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on July 17, 2013
BULLETIN # 73 Manitoba Drug Benefits and Interchangeability Formulary Amendments The following amendments will take effect on July 17, 2013 The amended Manitoba Specified Drug Regulation and Drug Interchangeability
Ontario Drug Benefit Formulary/Comparative Drug Index
Ontario Drug Benefit Formulary/Comparative Drug Index Edition 42 Summary of Changes - January 2015 Effective January 28, 2015 Ministry of Health and Long-Term Care Table of Contents New Multi-Source Products...
Summary of Changes to the Alberta Health and Wellness Drug Benefit List
Summary of Changes to the Alberta Health and Wellness Drug Benefit List Effective April 1, 2010 ABC 40211/81160 (R2010/04) Table of Contents Special Authorization...1 New Drug Product(s) Available by Special
BULLETIN # 52. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on September 14, 2006.
BULLETIN # 52 Manitoba Drug Benefits and Interchangeability Formulary Amendments The following amendments will take effect on September 14, 2006. The amended Manitoba Specified Drug Regulation and Drug
A BULLETIN FOR PHARMACY SERVICE PROVIDERS FROM ALBERTA BLUE CROSS. Pan-Canadian Select Molecule Price Initiative for Generic Drugs
Pharmacy Benefact A BULLETIN FOR PHARMACY SERVICE PROVIDERS FROM ALBERTA BLUE CROSS Number 723 February 2018 Pan-Canadian Select Molecule Price Initiative for Generic Drugs Alberta Drug Benefit List prices
Ontario Drug Benefit Formulary/Comparative Drug Index
Ontario Drug Benefit Formulary/Comparative Drug Index Edition 42 Summary of Changes - November 2014 Effective November 27, 2014 Ministry of Health and Long-Term Care Table of Contents New Single Source
UPDATE AA Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective September 15, 2011 SUMMARY OF CHANGES
UPDATE AA Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective September 15, 2011 SUMMARY OF CHANGES TABLE OF CONTENTS Page New Single Source Drug(s) 2 New Multi-Source Drug(s) 3 Off
Ontario Drug Benefit Formulary/Comparative Drug Index
Ministry of Health and Long-Term Care Ontario Drug Benefit Formulary/Comparative Drug Index Edition 43 Summary of Changes March 2019 Effective March 28, 2019 Drug Programs Policy and Strategy Branch Drugs
BULLETIN # 72. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on April 18, 2013
BULLETIN # 72 Manitoba Drug Benefits and Interchangeability Formulary Amendments The following amendments will take effect on April 18, 2013 The amended Manitoba Specified Drug Regulation and Drug Interchangeability
NB Drug Plans Formulary Update
Bulletin #942 January 27, 2017 NB Drug Plans Formulary Update Please find attached a list of generic drug product updates for the New Brunswick Drug Plans Formulary. Generic drug product additions New
DT Description Price Category Price change Percentage BNF 1.2 Mebeverine 135mg tablets (100) 759 M %
June 2016 On 13th May, the DH announced that there would be reductions to Category M prices from June until September. http://psnc.org.uk/our-news/contractor-notice-category-m-price-reduction/ This has
PRESCRIPTION SAVINGS CLUB FLAT- PRICED GENERIC DRUG LIST (EMDEON) Effective August 20, 2014
PRESCRIPTION SAVINGS CLUB FLAT- PRICED GENERIC DRUG LIST (EMDEON) Effective August 20, 2014 The Prescription Savings Club provides its members with significant savings on prescription medications. The
Ontario Drug Benefit Formulary/Comparative Drug Index
Ministry of Health and Long-Term Care Ontario Drug Benefit Formulary/Comparative Drug Index Edition 43 Summary of Changes August 2018 Effective August 30, 2018 Drug Programs Policy and Strategy Branch
BULLETIN # 80. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on January 19, 2015
BULLETIN # 80 Manitoba Drug Benefits and Interchangeability Formulary Amendments The following amendments will take effect on January 19, 2015 The amended Manitoba Specified Drug Regulation and Drug Interchangeability
Ontario Drug Benefit Formulary/Comparative Drug Index
Ministry of Health and Long-Term Care Ontario Drug Benefit Formulary/Comparative Drug Index Edition 43 Summary of Changes December 2018 Effective December 21, 2018 Drug Programs Policy and Strategy Branch
BULLETIN # 84. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on October 22, 2015
BULLETIN # 84 Manitoba Drug Benefits and Interchangeability Formulary Amendments The following amendments will take effect on October 22, 2015 The amended Manitoba Specified Drug Regulation and Drug Interchangeability
Nova Scotia Pharmacare Programs Interchangeable Product Updates November 13, 2018 New Categories
PAGE 1 OF 7 Nova Scotia Pharmacare Programs Interchangeable Product Updates November 13, New Categories A Maximum Reimbursable Price (MRP) or Pharmacare Reimbursement Price (PRP) has been established for
Ontario Drug Benefit Formulary/Comparative Drug Index
Ministry of Health and Long-Term Care Ontario Drug Benefit Formulary/Comparative Drug Index Edition 42 Summary of Changes June 2017 Effective June 29, 2017 Drug Programs Policy and Strategy Branch Ontario
NEW BRUNSWICK PRESCRIPTION DRUG PROGRAM FORMULARY
NEW BRUNSWICK PRESCRIPTION DRUG PROGRAM FORMULARY FORMULAIRE DU PLAN DE MÉDICAMENTS SUR ORDONNANCE DU NOUVEAU-BRUNSWICK MARCH 2012 MARS 2012 NEW BRUNSWICK PRESCRIPTION DRUG PROGRAM FORMULARY Copyright
SASKATCHEWAN FORMULARY COMMITTEE UPDATE BULLETIN TO THE 55th EDITION OF THE SASKATCHEWAN FORMULARY
Saskatchewan Health Drug Plan and Extended Benefits Branch October 2005 Bulletin #104 ISSN 0708-3246 SASKATCHEWAN FORMULARY COMMITTEE UPDATE BULLETIN TO THE 55th EDITION OF THE SASKATCHEWAN FORMULARY All
BULLETIN # 90. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on January 25, 2017
BULLETIN # 90 Manitoba Drug Benefits and Interchangeability Formulary Amendments The following amendments will take effect on January 25, 2017 The amended Manitoba Specified Drug Regulation and Drug Interchangeability
Archived Content. This content was archived on June 24, 2013.
This content was archived on June 24, 2013. Archived Content Information identified as archived on the Web is for reference, research or recordkeeping purposes. It has not been altered or updated after
SASKATCHEWAN FORMULARY COMMITTEE UPDATE BULLETIN 52nd Edition
Saskatchewan Health Drug Plan and Extended Benefits Branch April, 2003 Bulletin #94 ISSN 0708-3246 SASKATCHEWAN FORMULARY COMMITTEE UPDATE BULLETIN 52nd Edition NEW EXCEPTION DRUG STATUS AGENTS Effective
Ontario Drug Benefit Formulary/Comparative Drug Index
Ministry of Health and Long-Term Care Ontario Drug Benefit Formulary/Comparative Drug Index Edition 42 Summary of Changes September 2017 Effective September 28, 2017 Drug Programs Policy and Strategy Branch
SASKATCHEWAN FORMULARY COMMITTEE BULLETIN FOR THE UPDATE TO THE 56th EDITION OF THE SASKATCHEWAN FORMULARY
Saskatchewan Health Drug Plan and Extended Benefits Branch April 2007 Bulletin #110 ISSN 0708-3246 SASKATCHEWAN FORMULARY COMMITTEE BULLETIN FOR THE UPDATE TO THE 56th EDITION OF THE SASKATCHEWAN FORMULARY
Ontario Drug Benefit Formulary/Comparative Drug Index
Ontario Drug Benefit Formulary/Comparative Drug Index Edition 42 Summary of Changes - February 2015 Effective February 26, 2015 Ministry of Health and Long-Term Care Table of Contents New Multi-Source
Ontario Drug Benefit Formulary/Comparative Drug Index
Ontario Drug Benefit Formulary/Comparative Drug Index Edition 42 Summary of Changes - December 2014 Effective December 18, 2014 Ministry of Health and Long-Term Care Table of Contents New Multi-Source
DT Description Price Category Price change
Tariff T Watch October 2014 Readers are no doubt aware of this quarter's bad news for primary care prescribing allocations: NHS England has d the remuneration mechanism for community pharmacies gaining
Ontario Drug Benefit Formulary/Comparative Drug Index
Ministry of Health and Long-Term Care Ontario Drug Benefit Formulary/Comparative Drug Index Edition 43 Summary of Changes January 2018 Effective January 31, 2018 Drug Programs Policy and Strategy Branch
UPDATE AZ Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective October 31, 2013 SUMMARY OF CHANGES
UPDATE AZ Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective October 31, 2013 SUMMARY OF CHANGES TABLE OF CONTENTS Page New Single Source Drug(s) 2 New Multi-Source Drug(s) 5 Off Formulary
While there is around a 3% increase shown in costs for Category M lines, I think this is due to the inclusion of more lines in Category M.
April 2018 The usual quarterly of Category M prices Another set of similar comments as I made in January: significant increases in many lines which have been subject to price concessions but even more
NB Drug Plans Formulary Update
Bulletin #920 January 29, 2016 NB Drug Plans Formulary Update Please find attached a list of generic drug product updates for the New Brunswick Drug Plans Formulary. Generic drug product additions New
BULLETIN # 101. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on October 18, 2018
BULLETIN # 101 Manitoba Drug Benefits and Interchangeability Formulary Amendments The following amendments will take effect on October 18, 2018 The amended Manitoba Specified Drug Regulation and Drug Interchangeability
SASKATCHEWAN FORMULARY COMMITTEE UPDATE BULLETIN TO THE 55th EDITION OF THE SASKATCHEWAN FORMULARY
Saskatchewan Health Drug Plan and Extended Benefits Branch April 2006 Bulletin #106 ISSN 0708-3246 SASKATCHEWAN FORMULARY COMMITTEE UPDATE BULLETIN TO THE 55th EDITION OF THE SASKATCHEWAN FORMULARY All
Club Members save even more with the $4 Plus Plan!
Club Members save even more with the $4 Plus Plan! ITEM DESCRIPTION Acephen Supp 650MG 12 Acetam Tab 325MG 30 90 Acyclovir Cap 200MG 30 90 Albuterol Syr 2MG/5ML 120 360 Albuterol Sulfate Nebulizer Ud Sol
TennCare Program TN MAC Price Change List As of: 03/30/2017
1 TN List Run : 03/30/17 Old PRAZOSIN HCL 5 MG CAPSULE ORAL 03/29/2017 1.11209 1.12560 ( 1.2) CAPTOPRIL 12.5 MG TABLET ORAL 07/07/2015 1.07191 1.10416 ( 2.9) ISOSORBIDE DINITRATE 5 MG TABLET ORAL 03/29/2017
BULLETIN # 78. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on July 17, 2014
BULLETIN # 78 Manitoba Drug Benefits and Interchangeability Formulary Amendments The following amendments will take effect on July 17, 2014 The amended Manitoba Specified Drug Regulation and Drug Interchangeability
Summary of Changes to the Alberta Drug Benefit List
Summary of Changes to the Alberta Drug Benefit List Effective April 1, 2018 Inquiries should be directed to: Pharmacy Services Alberta Blue Cross 10009 108 Street NW Edmonton AB T5J 3C5 Telephone Number:
SASKATCHEWAN FORMULARY COMMITTEE BULLETIN UPDATE TO THE 54th EDITION
Saskatchewan Health Drug Plan and Extended Benefits Branch April 2005 Bulletin #102 ISSN 0708-3246 SASKATCHEWAN FORMULARY COMMITTEE BULLETIN UPDATE TO THE 54th EDITION All of the following new listings
Ontario Drug Benefit Formulary/Comparative Drug Index
Ministry of Health and Long-Term Care Ontario Drug Benefit Formulary/Comparative Drug Index Edition 42 Summary of Changes July 2017 Effective July 31, 2017 Drug Programs Policy and Strategy Branch Ontario
BULLETIN # 50. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on March 13, 2006.
BULLETIN # 50 Manitoba Drug Benefits and Interchangeability Formulary Amendments The following amendments will take effect on March 13, 2006. The amended Manitoba Specified Drug Regulation and Drug Interchangeability
BULLETIN # 102. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on January 24, 2019
BULLETIN # 102 Manitoba Drug Benefits and Interchangeability Formulary Amendments The following amendments will take effect on January 24, 2019 The amended Manitoba Specified Drug Regulation and Drug Interchangeability
UPDATE AB Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective October 25, 2011 SUMMARY OF CHANGES
UPDATE AB Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective October 25, 2011 SUMMARY OF CHANGES TABLE OF CONTENTS Page New Single Source Drug(s) 2 New Multi-Source Drug(s) 5 Off Formulary
Professionalism & Service with Great Prices
Acyclovir Capsules 200mg Viruses 30 90 Albuterol Syrup 2mg/5ml Asthma 120 360 Albuterol Sulfate Solution 0.05% * Asthma ----- ----- 20 60 Albuterol Sulfate Solution 0.083% Asthma ----- ----- 75 225 Alendronate
DT Description Price Category Price change Percentage BNF 1.2 Mebeverine 135mg tablets (100) 702 M %
December 16 No Category M changes so the reductions imposed in May which were only supposed to last until September continue As in November, most changes are Category A lines with a few Category C. Significant
Pharmacy Savings Program
Pharmacy Savings Program SELECT GENERICS DRUG LIST The Pharmacy Savings Program provides you with savings on select generic medications included on this list. The prices for these select generic medications
New Exception Status Benefits
JULY 2012 Nova Scotia Formulary Updates New Exception Status Benefits Criteria Update: Xarelto Criteria Update: Sutent New Diabetic Products PRP Non-Insured Products Pharmacare Reimbursement Changes to
Special Generic Drug Pricing Program
FREE PICK-UP & DELIVERY Flu-Shots Specialty prescription Compounding Wellness center providing health screenings for hypertension and diabetes $3 Special Generic Prescription Drug Program only offered
DT Description Price Category Price change Percentage
June 2017 A slight inflationary pressure in most CCGs from mainly Category A increases. Significant price increases: Most of low concern although those involving the less frequently used tamoxifen strengths
Archived Content. This content was archived on June 24, 2013.
This content was archived on June 24, 2013. Archived Content Information identified as archived on the Web is for reference, research or recordkeeping purposes. It has not been altered or updated after
Ontario Drug Benefit Formulary/Comparative Drug Index
Ontario Drug Benefit Formulary/Comparative Drug Index Edition 42 Summary of Changes - July 2014 Effective July 30, 2014 Ministry of Health and Long-Term Care Table of Contents New Single Source Products...
UPDATE Z Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective August 04, 2011 SUMMARY OF CHANGES
UPDATE Z Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective August 04, 2011 SUMMARY OF CHANGES TABLE OF CONTENTS Page New Single Source Drug(s) 2 New Multi-Source Drug(s) 4 Off Formulary
Cash Wise Pharmacy $4 GENERIC MEDICATION FORMULARY. Cash Wise Pharmacy s $4 generic medication formulary is sorted by medical condition.
Cash Wise Pharmacy $4 GENERIC MEDICATION FORMULARY Cash Wise Pharmacy s $4 generic medication formulary is sorted by medical condition. 30- day 90- day 30- day 90- day quantity quantity quantity quantity
Updates to the Alberta Drug Benefit List. Effective September 1, 2018
Updates to the Alberta Drug Benefit List Effective September 1, 2018 Inquiries should be directed to: Pharmacy Services Alberta Blue Cross 10009 108 Street NW Edmonton AB T5J 3C5 Telephone Number: (780)
Updates to the Alberta Health and Wellness Drug Benefit List
Updates to the Alberta Health and Wellness Drug Benefit List Effective May 1, 2012 UPDATES TO THE ALBERTA HEALTH AND WELLNESS DRUG BENEFIT LIST Inquiries should be directed to: Pharmacy Services Alberta
ANNOUNCEMENT. Dear Valued Customer:
ANNOUNCEMENT Dear Valued Customer: This is to notify you that Ranbaxy Canada s products will not be currently distributed to you through Kohl and Frisch; however Kohl and Frisch will continue their support
UPDATE AX Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective August 29, 2013 SUMMARY OF CHANGES
UPDATE AX Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective August 29, 2013 SUMMARY OF CHANGES TABLE OF CONTENTS Page New Single Source Drug(s) 2 New Multi-Source Drug(s) 4 Off Formulary
Home Delivery Prescription Program Drug List
Home Delivery Prescription Program Drug List Low-cost prescriptions, right in your mailbox. Now you can have your generic prescriptions mailed right to your home, no matter where you live. Because we think
Products and Pricing on the Alberta Blue Cross Drug Price List (ABCDPL) Effective May 15, 2015
00002192691 3TC 10 MG/ML ORAL LIQUID ORL LIQ GSK ML 0.3375 00002192683 3TC 150 MG TABLET ORL TAB GSK TAB 5.3543 00002247825 3TC 300 MG TABLET ORL TAB GSK TAB 10.3970 00002162113 5 BENZAGEL 5% TOPICAL (ALCOHOL)
SASKATCHEWAN FORMULARY COMMITTEE BULLETIN UPDATE TO THE 54th EDITION
Saskatchewan Health Drug Plan and Extended Benefits Branch January 2005 Bulletin #101 ISSN 0708-3246 SASKATCHEWAN FORMULARY COMMITTEE BULLETIN UPDATE TO THE 54th EDITION NEW FULL FORMULARY LISTING: The
ASEBP and ARTA TARP Drugs and Reference Price by Categories
ASEBP Pantoprazole Sodium 40 mg (generic) $0.2016 ASEBP Dexlansoprazole 30 mg Dexlansoprazole 60 mg Esomeprazole 10 mg Esomeprazole 20 mg Esomeprazole 40 mg Lansoprazole 15 mg Lansoprazole 30 mg Omeprazole
BULLETIN # 66. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on November 24, 2011.
BULLETIN # 66 Manitoba Drug Benefits and Interchangeability Formulary Amendments The following amendments will take effect on November 24, 2011. The amended Manitoba Specified Drug Regulation and Drug
Ontario Drug Benefit Formulary/Comparative Drug Index
Ontario Drug Benefit Formulary/Comparative Drug Index Edition 42 Summary of Changes - August 2015 Effective August 26, 2015 Ministry of Health and Long-Term Care Table of Contents New Single Source Products...